Literature DB >> 34326222

No shortcuts to SARS-CoV-2 antivirals.

Aled Edwards1,2, Ingo V Hartung1,2.   

Abstract

Year:  2021        PMID： 34326222     DOI： 10.1126/science.abj9488

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  4 in total

1.  Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens.

Authors:  Henry R O'Donnell; Tia A Tummino; Conner Bardine; Charles S Craik; Brian K Shoichet
Journal:  J Med Chem       Date:  2021-11-23       Impact factor: 7.446

2.  Antivirals against (Re)emerging Flaviviruses: Should We Target the Virus or the Host?

Authors:  María-Jesús Pérez-Pérez; Juan-Carlos Saiz; Eva-María Priego; Miguel A Martín-Acebes
Journal:  ACS Med Chem Lett       Date:  2021-12-08       Impact factor: 4.345

3.  Identification and Development of Therapeutics for COVID-19.

Authors:  Halie M Rando; Nils Wellhausen; Soumita Ghosh; Alexandra J Lee; Anna Ada Dattoli; Fengling Hu; James Brian Byrd; Diane N Rafizadeh; Ronan Lordan; Yanjun Qi; Yuchen Sun; Christian Brueffer; Jeffrey M Field; Marouen Ben Guebila; Nafisa M Jadavji; Ashwin N Skelly; Bharath Ramsundar; Jinhui Wang; Rishi Raj Goel; YoSon Park; Simina M Boca; Anthony Gitter; Casey S Greene
Journal:  mSystems       Date:  2021-11-02       Impact factor: 6.496

4.  What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?

Authors:  Miguel Angel Martinez
Journal:  Front Microbiol       Date:  2022-02-16       Impact factor: 5.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.